Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
WuXi PharmaTech (药明康德) has...
Wuxi MTLH Biotechnology Co., a company...
OriGene Technologies announced plans to build one...
Charles River Laboratories and WuXi...
WuXi PharmaTech, a dominant player in...
WuXi PharmaTech will collaborate with...
WuXi PharmaTech formed a collaboration...
WuXi PharmaTech sold a 5.55% stake in...
Ambrx Inc., a clinical-stage San Diego antibody-conjugate...
Cayman Islands-based WuXi Healthcare...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China